Sitagliptin Phosphate

fatty acid binding protein 4 ; Homo sapiens

2 Article(s)
Pub. Year
#Total Relationships
1 32539832 Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy. 2020 Jun 15 1
2 26467280 Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus. 2015 Dec 5